GENEDX HOLDINGS CORP. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 19.66 USD | +0.82% |
|
+77.44% | +614.91% |
| 30/04 | Health Care Flat Amid Mixed Earnings -- Health Care Roundup | DJ |
| 30/04 | Sector Update: Health Care Stocks Mixed Late Afternoon | MT |
Chart calendar GeneDx Holdings Corp.
b9ec3a9.ZvL_-tA82Gd66-DNFA3nJV6EWtAaIhpk_wDTEpibQKg.PsCWj5xXmxEvgKigJUiGHRDXFIV7cywis3CQWenUH9oisbqWn2q3NAuj2A~daef3ec494c229fd042726680ebd1d23
Upcoming events on GeneDx Holdings Corp.
Past events on GeneDx Holdings Corp.
| 30/04/2024 02:00 am | Q1 2024 Earnings Call |
| 29/04/2024 | Q1 2024 Earnings Release After hours |
| 25/04/2024 10:30 pm | World Orphan Drug Congress |
| 15/03/2024 08:00 pm | American College of Medical Genetics and Genomics Conference |
| 14/03/2024 09:00 pm | American College of Medical Genetics and Genomics Conference |
| 14/03/2024 08:00 pm | American College of Medical Genetics and Genomics Conference |
| 06/03/2024 09:00 pm | TD Cowen Health Care Conference |
| 21/02/2024 03:00 am | Q4 2023 Earnings Call |
| 21/02/2024 02:56 am | Q4 2023 Earnings Release |
| 08/01/2024 | JPMorgan Healthcare Conference |
| 01/12/2023 | American Epilepsy Society Meeting |
| 30/11/2023 09:20 pm | Evercore ISI HealthCONx Conference |
| 31/10/2023 02:00 am | Q3 2023 Earnings Call |
| 31/10/2023 01:35 am | Q3 2023 Earnings Release |
| 09/08/2023 02:00 am | Q2 2023 Earnings Call |
| 09/08/2023 01:35 am | Q2 2023 Earnings Release |
| 30/06/2023 03:15 am | United Mitochondrial Disease Foundation Mitochondrial Medicine Symposium |
| 14/06/2023 06:30 pm | Annual General Meeting |
| 12/06/2023 09:50 pm | Goldman Sachs Global Healthcare Conference |
| 08/06/2023 01:30 am | Jefferies Global Healthcare Conference |
Annual results
| Fiscal Period | December | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 | 212 205 3.44% | 235 246 -4.66% | 203 198 2.12% | 243 |
|
EBITDA Million USD | Released Forecast Spread | 0,00 | -200 -185 -7.87% | -267 -292 8.59% | -94,6 -117 18.94% | -21,4 |
|
EBIT Million USD | Released Forecast Spread | 0,00 | -221 -306 27.55% | -326 -323 -0.89% | -128 -131 1.75% | -30,4 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,00 | -245 -280 12.36% | -598 -325 -83.78% | 0,00 0,00 - | 0,00 |
|
Net income Million USD | Released Forecast Spread | -39 908 | -245 -272 9.72% | -549 -276 -98.69% | -176 -203 13.59% | -77,3 |
|
EPS USD | Released Forecast Spread | -124 | -74,9 -39,8 -88.38% | -53,8 -30,5 -76.22% | -7,23 -8,58 15.73% | -2,87 |
| Announcement Date | 06/05/21 | 14/03/22 | 14/03/23 | 20/02/24 | - |
Quarterly results
| Fiscal Period | December | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 53,9 50,2 7.52% | 36,2 67,6 -46.46% | 83,2 67,7 22.87% | 61,4 73,9 -17.01% | 43,1 39,2 10.01% | 48,7 47,6 2.26% | 53,3 52,4 1.71% | 57,4 57,6 -0.39% | 62,4 49,5 26.23% | 59,4 | 59,8 | 61,8 | 60,2 | 66,9 |
|
EBITDA Million USD | Released Forecast Spread | -58,9 -85,4 31.06% | -115 -66,9 -72.08% | -70,0 -82,4 14.99% | -38,7 -63,7 39.25% | -40,2 -36,1 -11.42% | -43,1 -27,8 -55.38% | -22,4 -21,2 -5.56% | -11,1 -19,4 42.65% | -2,77 -22,6 87.71% | -7,00 | -5,80 | -3,80 | -2,45 | 0,65 |
|
EBIT Million USD | Released Forecast Spread | -64,7 -79,7 18.85% | -122 -51,2 -137.85% | -77,0 -58,1 -32.71% | -72,7 -59,8 -21.7% | -48,9 -29,3 -66.68% | -51,6 -32,7 -58.02% | -31,1 -34,0 8.71% | -17,2 -17,1 -0.82% | -8,02 -17,0 52.7% | -7,89 | -7,80 | -6,32 | -5,00 | -5,50 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -76,9 -68,9 -11.61% | -135 -87,3 -54.43% | -77,6 -84,5 8.11% | -309 -61,1 -405.19% | ||||||||||
|
Net income Million USD | Released Forecast Spread | -76,9 -99,9 23.03% | -85,7 -87,9 2.4% | -77,6 -113 31.34% | -309 -61,1 -405.34% | -61,0 -63,0 3.19% | -46,7 -34,6 -35.03% | -42,3 -30,7 -37.74% | -25,8 -44,5 42.08% | -20,2 -41,7 51.47% | -19,6 | -19,0 | -17,6 | -16,8 | -10,7 |
|
EPS USD | Released Forecast Spread | -10,2 -11,9 13.89% | -8,25 -7,92 -4.17% | -6,60 -9,90 33.33% | -29,0 -6,93 -319.05% | -3,04 -2,64 -15.15% | -1,84 -1,35 -36.3% | -1,64 -1,18 -38.98% | -0,92 -1,69 45.56% | -0,78 -1,55 49.68% | -0,74 | -0,69 | -0,63 | -0,58 | -0,36 |
| Announcement Date | 12/05/22 | 15/08/22 | 14/11/22 | 14/03/23 | 09/05/23 | 08/08/23 | 30/10/23 | 20/02/24 | 29/04/24 | - | - | - | - | - |
| 08/05/2024 01:35 am | OPKO HEALTH, INC.: Q1 2024 Earnings Release |
| 08/05/2024 | VIJAYA DIAGNOSTIC CENTRE LIMITED: Q4 2024 Earnings Release |
| 08/05/2024 | RADNET, INC.: Q1 2024 Earnings Release |
| 08/05/2024 | SYNLAB AG: Q1 2024 Earnings Release |
| 09/05/2024 | FLEURY S.A.: Q1 2024 Earnings Release |
| 10/05/2024 | H.U. GROUP HOLDINGS, INC.: Q4 2023 Earnings Release |
| 10/05/2024 | DR. LAL PATHLABS LIMITED: Q4 2024 Earnings Release |
| 10/05/2024 | BML, INC.: Q4 2023 Earnings Release |
| 14/05/2024 | METROPOLIS HEALTHCARE LIMITED: Q4 2024 Earnings Release (Projected) |
| 25/07/2024 | DR. LAL PATHLABS LIMITED: Q1 2025 Earnings Release (Projected) |
Past sector events for GeneDx Holdings Corp.
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- WGS Stock
- Calendar GeneDx Holdings Corp.
